| Application no. and date | 16876612.9 (espacenet) (Federated) (European Patent Register), 20161214 | | Patent/reg. no. and date | DK/EP 3389699, 20240501 | | Publication date | 20181024 | | Priority no. and date | US 201562267735 P, 20151215, US 201662309169 P, 20160316, US 201662359036 P, 20160706 | | EP pub. no. and date |
EP 3389699 20181024 | | Effective date | | | Applicant/owner | OncoC4, Inc., 9640 Medical Center Drive
Rockville, MD 20850, US | | Applicant ref. no. | V475876DK00 | | Inventor | LIU, Yang, 502 E Street NE
Washington, District of Columbia 20002, US,
ZHENG, Pan, 502 E Street NE
Washington, District of Columbia 20002, US,
DEVENPORT, Martin, 614 Still Creek Lane
Gaithersburg, Maryland 20878, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Kimæriske og humaniserede anti-humane CTLA4-monoklonale antistoffer og anvendelser deraf | | Int. application no. | US2016066698 | | Int. publication no. | WO2017106372 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
